ISPOR Europe Health Policy Update: Impacts of the EU Pharmaceutical Legislation Reform and the HTA Regulation on CEE Countries

Speaker(s)

Oresta Piniazhko, PhD, State Expert Center of the Ministry of Health of Ukraine, Kyiv, Ukraine, Iga Lipska, MD, PhD, MPH, Health Policy Institute, Medical University of Gdańsk, Gdańsk, Poland and Momir Radulović, -, Agency for Medicinal Products and Medical Devices (JAZMP), Ljubljana, Slovenia

Hosted by the ISPOR Central and East Europe (CEE) Consortium, this meeting will present timely updates of health economics and health policy in Europe. The session will discuss the reform of EU pharmaceutical legislation and the EU regulation of HTA by focusing on how these EU-wide collective efforts will impact CEE countries. What do these changes mean for CEE countries in terms of realigning health systems, contexts, and key players? How should CEE prepare for implementing policy reforms and what are the main challenges affecting implementation? Speakers will present unique perspectives and insights, highlight key issues, and provide recommendations on practical implementation for CEE. A Question and Answer (Q & A) section will be offered at the end of presentations.